Barclays PLC Stryker Corp Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$315.94 - $371.96 $4.93 Million - $5.8 Million	-15,600 Reduced 93.41%	1,100 $397,000
Q2 2024 Aug 14, 2024	BUY	$324.3 - $354.67 $5.42 Million - $5.92 Million	16,700 New	16,700 $5.68 Million
Q4 2023 Feb 15, 2024	BUY	$253.85 - $299.46 $1.68 Million - $1.98 Million	6,600 New	6,600 $1.98 Million
Q1 2020 May 13, 2020	SELL	$126.5 - $225.1 $1.16 Million - $2.07 Million	-9,200 Reduced 30.98%	20,500 $3.41 Million
Q4 2019 Feb 10, 2020	SELL	$197.98 - $220.53 $24.3 Million - $27 Million	-122,500 Reduced 80.49%	29,700 $6.24 Million
Q3 2019 Nov 14, 2019	SELL	$205.4 - $221.82 $1.93 Million - $2.09 Million	-9,400 Reduced 5.82%	152,200 $32.9 Million
Q2 2019 Aug 14, 2019	SELL	$180.24 - $205.58 $11.9 Million - $13.6 Million	-66,000 Reduced 29.0%	161,600 $33.2 Million
Q1 2019 May 15, 2019	BUY	$152.46 - $198.0 $31.1 Million - $40.4 Million	204,000 Added 864.41%	227,600 $45 Million
Q4 2018 Feb 14, 2019	BUY	$145.0 - $178.65 $1.58 Million - $1.95 Million	10,900 Added 85.83%	23,600 $3.7 Million
Q3 2018 Nov 14, 2018	SELL	$163.25 - $177.68 $12.7 Million - $13.8 Million	-77,900 Reduced 85.98%	12,700 $2.26 Million
Q2 2018 Aug 14, 2018	BUY	$155.17 - $179.78 $11.6 Million - $13.5 Million	75,000 Added 480.77%	90,600 $15.3 Million
Q1 2018 May 15, 2018	BUY	$148.01 - $168.91 $769,652 - $878,332	5,200 Added 50.0%	15,600 $2.51 Million
Q4 2017 Feb 14, 2018	SELL	$143.51 - $159.74 $1.08 Million - $1.2 Million	-7,500 Reduced 41.9%	10,400 $1.61 Million
Q3 2017 Nov 14, 2017	BUY	$138.36 - $147.87 $2.48 Million - $2.65 Million	17,900	17,900 $2.54 Million

Others Institutions Holding SYK

# of Institutions

2,231

Shares Held

284M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $140B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account